# Butea monosperma

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/butea-monosperma
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Ayurveda
**Also Known As:** Butea frondosa, Flame of the Forest, Palash, Dhak, Tesu, Bastard Teak, Palas

## Overview

Butea monosperma is an Ayurvedic herb containing flavonoids like butein and butin that exhibits nephroprotective and anti-inflammatory properties. The plant modulates [inflammatory pathway](/ingredients/condition/inflammation)s and [oxidative stress](/ingredients/condition/antioxidant) markers in preliminary studies.

## Health Benefits

• Kidney protection: Ethanolic leaf extract (400 mg/kg) significantly reduced markers of kidney damage in animal studies (P<0.001) - Preliminary evidence only
• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Flower extract suppressed inflammatory markers (IL-6, MMP-3, MMP-9, MMP-13) in osteoarthritis cell studies - In vitro evidence only
• DNA protection: Leaf extracts reduced genetic damage markers by up to 80% in mice exposed to chemotherapy drugs - Animal studies only
• [Bone health](/ingredients/condition/bone-health) support: Bark extract promoted bone cell development via Wnt/β-catenin pathway activation - Cell culture evidence only
• [Antioxidant activity](/ingredients/condition/antioxidant): Extracts reduced oxidative stress markers and increased [glutathione](/ingredients/condition/detox) levels in multiple animal models - No human data available

## Mechanism of Action

Butea monosperma's flavonoids, particularly butein and butin, inhibit [inflammatory](/ingredients/condition/inflammation) mediators including IL-6, MMP-3, MMP-9, and MMP-13 in cellular models. The ethanolic leaf extracts appear to reduce [oxidative stress](/ingredients/condition/antioxidant) markers and modulate kidney function parameters. These compounds likely work through antioxidant pathways and matrix metalloproteinase inhibition.

## Clinical Summary

Current evidence is limited to animal and cellular studies with no human clinical trials available. Animal research using 400 mg/kg ethanolic leaf extract showed significant reduction in kidney damage markers (P<0.001). Cell culture studies demonstrated suppression of [inflammatory](/ingredients/condition/inflammation) markers in osteoarthritis models. The preliminary nature of these findings requires validation in human subjects before therapeutic claims can be substantiated.

## Nutritional Profile

Butea monosperma (Flame of the Forest) contains bioactive compounds across multiple plant parts. Flowers: flavonoids including butrin (0.5–1.2% dry weight), isobutrin, butin, and coreopsin; chalcones such as butein and isobutein. Seeds: contain fixed oils (~18–20% by weight) rich in palmitic, oleic, and linoleic fatty acids; toxic alkaloids including monospermine; lectins with hemagglutinating activity. Bark: tannins (~8–12% dry weight), palasonin (a anthelmintic principle), and β-sitosterol. Leaves: flavonol glycosides, medicarpin (a pterocarpan), and cajanin; crude protein approximately 12–15% dry weight in leaf meal; crude fiber ~18–22%. Roots: isoflavonoids including prunetin and biochanin-A. Gum (Palash gum): polysaccharide-rich (~70–80%), composed of arabinose, galactose, and glucuronic acid residues. Minerals detected in leaf extract: iron (~180 mg/100g dry weight), calcium (~1,200 mg/100g), zinc (~12 mg/100g), and phosphorus (~300 mg/100g) — values are approximate from regional phytochemical studies. Bioavailability notes: butrin and isobutrin show moderate oral bioavailability in animal models; palasonin is poorly absorbed systemically but acts locally in the GI tract; flavonoids undergo hepatic conjugation reducing systemic availability; seed lectins are denatured by heat, limiting bioactivity in processed preparations. Note: Most compositional data derives from Indian subcontinent plant specimens; significant variability exists based on soil, season, and plant part.

## Dosage & Preparation

Animal studies used ethanolic leaf extract at 200-400 mg/kg body weight daily for 7-8 days. No human dosage data is available. Chronic seed powder administration showed reproductive toxicity in rats after 3 months. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for Butea monosperma supplementation is extremely limited with no established dosing guidelines for humans. Potential interactions with medications metabolized through liver enzymes remain unknown. Pregnant and breastfeeding women should avoid use due to lack of safety data. Individuals with kidney conditions should consult healthcare providers before use given the herb's effects on renal parameters.

## Scientific Research

All available evidence for Butea monosperma is limited to preclinical animal and in vitro studies, with no human clinical trials, RCTs, or meta-analyses identified. Key studies include nephroprotection in rats (n=20-25 per group), anticlastogenic effects in mice (n=3-6 per group), and cell culture work on osteoarthritis chondrocytes and cancer cells.

## Historical & Cultural Context

Butea monosperma holds prominence in Ayurvedic medicine as a versatile phytomedicine, used historically for [anti-inflammatory](/ingredients/condition/inflammation), anticancer, wound healing, antidiabetic, and nephroprotective purposes. Traditional applications span centuries in Indian traditional systems, with bark, leaves, flowers, and seeds employed therapeutically.

## Synergistic Combinations

Turmeric, Ashwagandha, Boswellia, Ginger, Triphala

## Frequently Asked Questions

### What is the active dose of Butea monosperma?

Animal studies used 400 mg/kg of ethanolic leaf extract, but no human dosing guidelines exist. Clinical trials are needed to establish safe and effective dosing for humans.

### How does Butea monosperma protect kidneys?

The ethanolic leaf extract reduces kidney damage markers in animal studies, likely through antioxidant mechanisms and reduction of oxidative stress. Human studies are needed to confirm these nephroprotective effects.

### Can Butea monosperma help with arthritis?

Cell studies show flower extracts suppress inflammatory markers IL-6, MMP-3, MMP-9, and MMP-13 associated with osteoarthritis. However, no human trials have tested its effectiveness for joint conditions.

### What are Butea monosperma's main compounds?

The primary bioactive compounds are flavonoids including butein, butin, and other polyphenolic substances. These compounds are responsible for the herb's observed anti-inflammatory and antioxidant activities in laboratory studies.

### Is Butea monosperma safe for daily use?

Safety for regular human consumption is unknown due to lack of clinical studies. No adverse effects were reported in short-term animal studies, but long-term safety data is unavailable.

### Does Butea monosperma interact with kidney medications or diuretics?

While Butea monosperma shows kidney-protective properties in animal studies, there is currently insufficient clinical data to confirm specific interactions with diuretics or kidney medications. Anyone taking prescription medications for kidney health or hypertension should consult their healthcare provider before adding Butea monosperma supplements, as the ingredient may potentiate certain drug effects. No serious drug interactions have been documented in human studies to date.

### What is the difference between Butea monosperma leaf extract and flower extract?

Butea monosperma leaf extracts have been studied primarily for kidney protection and antioxidant (DNA-protective) effects, while flower extracts show specific activity against inflammatory markers associated with osteoarthritis (IL-6, MMP enzymes). Both parts contain bioactive compounds, but available research suggests leaf extracts may be more potent for systemic kidney and antioxidant benefits, whereas flower extracts are better suited for inflammatory joint conditions. Most commercial supplements use leaf material, though formulation potency varies widely.

### How strong is the current clinical evidence for Butea monosperma's health benefits?

Current evidence for Butea monosperma is primarily derived from animal studies and in vitro cell models rather than human clinical trials, classifying it as preliminary evidence only. The kidney protection data (400 mg/kg dose showing P<0.001 significance) and anti-inflammatory findings are promising but cannot yet be directly translated to human supplementation recommendations. More rigorous human studies are needed to establish safe and effective dosing, efficacy rates, and long-term safety profiles.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*